Tumour Suppressor Genes in Sporadic Epithelial Ovarian Cancer
Overview
Authors
Affiliations
Ovarian cancer is the most frequent cause of death from gynaecological malignancies in the western world, and sporadic epithelial ovarian cancer is its most predominant form. The aetiology of sporadic ovarian cancer remains unknown. Genetic studies have enabled a better understanding of the evolution of tumour progression. A major focus of research has been to identify tumour suppressor genes implicated in sporadic ovarian cancer over the past decade. Several tumour suppressor genes have been identified by strategies such as positional cloning and differential expression display. Further research is warranted to understand fully their contribution to the pathogenesis of sporadic ovarian cancer.
Pathway modulations and epigenetic alterations in ovarian tumorbiogenesis.
Saldanha S, Tollefsbol T J Cell Physiol. 2013; 229(4):393-406.
PMID: 24105793 PMC: 3875779. DOI: 10.1002/jcp.24466.
Wojnarowicz P, Gambaro K, De Ladurantaye M, Quinn M, Provencher D, Mes-Masson A Oncogenesis. 2013; 1:e27.
PMID: 23552840 PMC: 3503293. DOI: 10.1038/oncsis.2012.25.
E2F5 status significantly improves malignancy diagnosis of epithelial ovarian cancer.
Kothandaraman N, Bajic V, Brendan P, Huak C, Keow P, Razvi K BMC Cancer. 2010; 10:64.
PMID: 20181230 PMC: 2841139. DOI: 10.1186/1471-2407-10-64.
Large-scale genomic analysis of ovarian carcinomas.
Gorringe K, Campbell I Mol Oncol. 2009; 3(2):157-64.
PMID: 19383377 PMC: 5527877. DOI: 10.1016/j.molonc.2008.12.005.
Reduced expression of chemokine (C-C motif) ligand-2 (CCL2) in ovarian adenocarcinoma.
Arnold J, Huggard P, Cummings M, Ramm G, Chenevix-Trench G Br J Cancer. 2005; 92(11):2024-31.
PMID: 15900302 PMC: 2361786. DOI: 10.1038/sj.bjc.6602596.